AFT to announce full year results on May 23 2024

3 May 2024


AFT Pharmaceuticals to announce full year results on Thursday May 23 2024


AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release
its full year FY2024, ended March 31 2024, results on Thursday May 23 2024. The release
will be issued at around 09:00 am (NZT) on the NZX and ASX.

Following the release, management will present via webinar at 10:30 am (NZT).
Presentation material will be available on the company’s website AFT, the NZX website
NZX and the ASX website ASX.

To participate in the upcoming earnings webinar, please pre-register with the
provided link, below. Webinar details will be provided upon completion of your
registration.

Registration Link: AFT results presentation FY2024


For and on behalf of AFT Pharmaceuticals Limited, Malcolm Tubby, CFO.

For more information:


Investors Media
Malcolm Tubby Richard Inder
CFO, AFT Pharmaceuticals Ltd The Project
Phone: +64 9 488 0232 Phone: 021 645 643
Email: malcolm@aftpharm.com Email: richard@theproject.co.nz




About AFT Pharmaceuticals
AFT is a growing multinational pharmaceutical company that develops, markets and
distributes a broad portfolio of pharmaceutical products across a wide range of
therapeutic categories which are distributed across all major pharmaceutical
distribution channels: over-the-counter (OTC), prescription and hospital. Our product
portfolio comprises both proprietary and in-licensed products, and includes patented,
branded and generic drugs. Our business model is to develop and in-license products
for sale by our own dedicated sales teams in our home markets of Australia and New
Zealand and in certain Southeast Asian markets, and to out-license our products to
local licensees and distributors to the rest of the world. For more information:
aftpharm.com